Sirio Pharma News

Sirio Pharma: China Merchants Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Xianle Health Technology Co., Ltd.

May 8 18:30

Sirio Pharma: China Merchants Securities Co., Ltd.'s summary report on the continuous supervision and sponsorship of Xianle Health Technology Co., Ltd.'s issuance of convertible corporate bonds to unspecified targets

May 8 18:30

Sirio Pharma: Announcement on holding an online results briefing for 2023 and the first quarter of 2024

May 7 16:02

Sirio Pharma: China Merchants Securities Co., Ltd.'s 2023 Continuous Supervision Site Inspection Report on Xianle Health Technology Co., Ltd.

Apr 26 00:00

Sirio Pharma: Notice on completing the registration of industrial and commercial changes and obtaining a new business license

Apr 26 00:00

Xianle Health: Investor Relations Activity Record List for April 23, 2024

Apr 23 23:05

Xianle Health: Announcement on Adding Provisional Proposals for the 2023 Annual General Meeting of Shareholders and Supplementary Notice of the Shareholders' Meeting

Apr 22 19:49

Xianle Health: Announcement of Resolutions of the 32nd Meeting of the Third Board of Directors

Apr 22 19:49

Xianle Health: Notice on requesting the shareholders' meeting to authorize the board of directors to handle matters relating to small amount of rapid financing

Apr 22 19:49

Xianle Health: Announcement of Resolutions of the 27th Meeting of the 3rd Board of Supervisors

Apr 22 19:48

Xianle Health: 2023 Independent Director Debriefing Report (Takami)

Apr 22 00:00

Xianle Health: 2023 Annual Report Disclosure Reminder

Apr 22 00:00

Xianle Health: Report of the Audit Committee of the Board of Directors on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties

Apr 22 00:00

Xianle Health: The Board's Special Opinion on the Independent Director Assessment

Apr 22 00:00

Xianle Health: China Merchants Securities Co., Ltd.'s special inspection opinion on the storage and use of funds raised by Xianle Health Technology Co., Ltd. in 2023

Apr 22 00:00

Xianle Health: Feasibility analysis report of Xianle Health Technology Co., Ltd. on developing foreign exchange derivatives trading business in 2024

Apr 22 00:00

Xianle Health: Special Report on the Deposit and Actual Use of Funds Raised (as of December 31, 2023)

Apr 22 00:00

Xianle Health: Announcement on the Company's 2024 Foreign Exchange Derivatives Trading Business

Apr 22 00:00

Xianle Health: Special Report on Self-Inspection of Independent Directors' Independence

Apr 22 00:00

Xianle Health: Announcement on the Company's 2024 Cash Management Allowance Using Idle Own Funds

Apr 22 00:00